Comparison of a Compound With Pilocarpine and Brimonidine to Improve Near Vision in Healthy Presbyopic Patients

• Status: Recruiting
• Trial end date: 2021-09-10
• Target enrollment: 0
• Participant gender: All

Summary

Safety and Efficacy of Pilocarpine, Brimonidine, Oxymetazoline, Hyaluronic acid, Bromfenac (PBOHB) ophthalmic compound compared to Pilocarpine and Brimonidine to improve uncorrected near vision in healthy presbyopic patients one hour after instillation.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Optall Vision
• Treatments: Brimonidine Tartrate; Bromfenac; Hyaluronic Acid; Oxymetazoline; Phenylephrine; Pilocarpine

Criteria

Inclusion Criteria:

• Healthy

• Presbyopic

• 40 - 59 years

Exclusion Criteria:

• Diabetics

• Previous eye surgery

• Previous eye disease

• > 0.50 myopia

• > 1.5 hyperopia or astigmatism